|
JPS6333341A
(ja)
|
1986-07-28 |
1988-02-13 |
Seitetsu Kagaku Co Ltd |
配糖体の処理方法
|
|
US4843071A
(en)
|
1986-12-05 |
1989-06-27 |
Serotonin Industries Of Charleston |
Method and composition for treating obesity, drug abuse, and narcolepsy
|
|
JP2851054B2
(ja)
|
1989-03-15 |
1999-01-27 |
サントリー株式会社 |
ベンズオキセピン誘導体
|
|
US5169780A
(en)
|
1989-06-22 |
1992-12-08 |
Celgene Corporation |
Enantiomeric enrichment and stereoselective synthesis of chiral amines
|
|
FR2656310B1
(fr)
|
1989-12-22 |
1992-05-07 |
Roussel Uclaf |
Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
|
|
US5378475A
(en)
|
1991-02-21 |
1995-01-03 |
University Of Kentucky Research Foundation |
Sustained release drug delivery devices
|
|
CA2157594A1
(en)
|
1993-03-10 |
1994-09-15 |
Leah L. Frye |
Steroid derivatives, pharmaceutical compositions containing them, and their use as antibiotics or disinfectants
|
|
IT1265001B1
(it)
|
1993-12-16 |
1996-10-17 |
Zambon Spa |
Composizione farmaceutica per uso topico contenente acido (s)-2-(4- isobutilfenil) propionico
|
|
CA2179029C
(en)
|
1993-12-30 |
2009-02-24 |
Philip W. Ingham |
Vertebrate embryonic pattern-inducing hedgehog-like proteins
|
|
US6281332B1
(en)
|
1994-12-02 |
2001-08-28 |
The Johns Hopkins University School Of Medicine |
Hedgehog-derived polypeptides
|
|
JPH11514999A
(ja)
|
1995-10-10 |
1999-12-21 |
ストルーブ，マリリン |
ビタミンｄおよびその誘導体による掻痒症治療
|
|
EP0916637B1
(en)
|
1995-12-06 |
2005-04-20 |
Japan Science and Technology Agency |
Process for preparating optically active compounds
|
|
US6887820B1
(en)
|
1995-12-06 |
2005-05-03 |
Japan Science And Technology Corporation |
Method for producing optically active compounds
|
|
GB9706321D0
(en)
|
1997-03-26 |
1997-05-14 |
Zeneca Ltd |
Catalytic hydrogenation
|
|
US6238876B1
(en)
|
1997-06-20 |
2001-05-29 |
New York University |
Methods and materials for the diagnosis and treatment of sporadic basal cell carcinoma
|
|
US7741298B2
(en)
|
1997-06-20 |
2010-06-22 |
New York University |
Method and compositions for inhibiting tumorigenesis
|
|
US7709454B2
(en)
|
1997-06-20 |
2010-05-04 |
New York University |
Methods and compositions for inhibiting tumorigenesis
|
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
|
US6231875B1
(en)
|
1998-03-31 |
2001-05-15 |
Johnson & Johnson Consumer Companies, Inc. |
Acidified composition for topical treatment of nail and skin conditions
|
|
US7291626B1
(en)
*
|
1998-04-09 |
2007-11-06 |
John Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6867216B1
(en)
|
1998-04-09 |
2005-03-15 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signal pathways, compositions and uses related thereto
|
|
US6432970B2
(en)
|
1998-04-09 |
2002-08-13 |
Johns Hopkins University School Of Medicine |
Inhibitors of hedgehog signaling pathways, compositions and uses related thereto
|
|
AU755943B2
(en)
*
|
1998-08-13 |
2003-01-02 |
University Of Southern California |
Methods to increase blood flow to ischemic tissue
|
|
GB9821067D0
(en)
|
1998-09-29 |
1998-11-18 |
Zeneca Ltd |
Transfer hydrogenation process
|
|
US6291516B1
(en)
*
|
1999-01-13 |
2001-09-18 |
Curis, Inc. |
Regulators of the hedgehog pathway, compositions and uses related thereto
|
|
FR2796938B1
(fr)
|
1999-07-29 |
2004-04-02 |
Ppg Sipsy |
Nouveaux derives chiraux n-substitues de la norephedrine, leur preparation et leur utilisation pour la synthese de composes fonctionnalises optiquement actifs par transfert d'hydrogene
|
|
US20070021493A1
(en)
|
1999-09-16 |
2007-01-25 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
EP1216234B1
(en)
|
1999-09-16 |
2004-12-29 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
US6993456B2
(en)
|
1999-09-30 |
2006-01-31 |
Rockwell Automation Technologies, Inc. |
Mechanical-electrical template based method and apparatus
|
|
JP5420128B2
(ja)
|
1999-10-13 |
2014-02-19 |
ジョンズ ホプキンス ユニバーシティ スクール オブ メディシン |
ヘッジホッグ経路の調節物質、並びにそれに関する組成物及び利用法
|
|
US6552016B1
(en)
|
1999-10-14 |
2003-04-22 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
CA2388468C
(en)
|
1999-10-14 |
2011-01-25 |
Curis, Inc. |
Mediators of hedgehog signalling pathways, compositions and uses related thereto
|
|
US6893637B1
(en)
|
1999-10-21 |
2005-05-17 |
Zymogenetics, Inc. |
Method of treating fibrosis
|
|
IL133809A0
(en)
|
1999-12-30 |
2001-04-30 |
Yeda Res & Dev |
Steroidal alkaloids and pharmaceutical compositions comprising them
|
|
KR20010077591A
(ko)
|
2000-02-03 |
2001-08-20 |
복성해 |
아라니콜라 프로테오리티쿠스에서 분리한 신규 금속성단백질 분해효소 및 그의 유전자
|
|
ATE305786T1
(de)
|
2000-03-30 |
2005-10-15 |
Curis Inc |
Kleine organische moleküle als regulatoren der zellproliferation
|
|
US6613798B1
(en)
|
2000-03-30 |
2003-09-02 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
AU2001264595A1
(en)
|
2000-05-19 |
2001-12-03 |
Guilford Pharmaceuticals Inc. |
Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses
|
|
US7708998B2
(en)
|
2000-10-13 |
2010-05-04 |
Curis, Inc. |
Methods of inhibiting unwanted cell proliferation using hedgehog antagonists
|
|
CA2425356C
(en)
|
2000-10-13 |
2015-10-06 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
GB0029356D0
(en)
|
2000-12-01 |
2001-01-17 |
Avecia Ltd |
Transfer hydrogenation
|
|
US6456928B1
(en)
|
2000-12-29 |
2002-09-24 |
Honeywell International Inc. |
Prognostics monitor for systems that are subject to failure
|
|
JP5354763B2
(ja)
|
2001-03-16 |
2013-11-27 |
アルザ・コーポレーシヨン |
フェンタニルを投与するための経皮的張り付け剤
|
|
EP1401469A2
(en)
|
2001-04-09 |
2004-03-31 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
AUPR602401A0
(en)
|
2001-06-29 |
2001-07-26 |
Smart Drug Systems Inc |
Sustained release delivery system
|
|
RU2308948C2
(ru)
*
|
2001-07-02 |
2007-10-27 |
ТАШ Шинан |
Применение циклопамина для лечения базально-клеточной эпителиомы (карциномы) и других опухолей
|
|
EP1411938B1
(en)
*
|
2001-07-02 |
2005-07-06 |
Tas, Sinan |
Use of cyclopamine for the manufacture of a medicament for the treatemnt of psoriasis
|
|
JP2004536045A
(ja)
|
2001-07-02 |
2004-12-02 |
タシ、シナン |
基底細胞癌及び他の腫瘍の治療におけるシクロパミンの使用方法
|
|
WO2003011219A2
(en)
|
2001-07-27 |
2003-02-13 |
Curis, Inc. |
Mediators of hedgehog signaling pathways, compositions and uses related thereto
|
|
JP2003192919A
(ja)
|
2001-10-17 |
2003-07-09 |
Asahi Denka Kogyo Kk |
難燃性合成樹脂組成物
|
|
WO2003040150A1
(en)
|
2001-11-09 |
2003-05-15 |
Yun Chi |
Volatile noble metal organometallic complexes
|
|
US7105637B2
(en)
|
2002-02-15 |
2006-09-12 |
William Marsh Rice University |
Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), methods of their synthesis
|
|
JP2005527508A
(ja)
*
|
2002-03-07 |
2005-09-15 |
ヴェクトゥラ リミテッド |
経口デリバリー用急速溶融多粒子製剤
|
|
ATE404200T1
(de)
|
2002-04-22 |
2008-08-15 |
Univ Johns Hopkins Med |
Modulatoren von hedgehog signalpfaden, zusammensetzungen und verwandte verwendungen
|
|
GB0210234D0
(en)
|
2002-05-03 |
2002-06-12 |
Novartis Ag |
Process for the manufacture of organic compounds
|
|
US20050203061A1
(en)
|
2002-06-20 |
2005-09-15 |
Shinya Yamashita |
Prodrug, medicinal utilization thereof and process for producing the same
|
|
WO2004020599A2
(en)
|
2002-08-29 |
2004-03-11 |
Curis, Inc. |
Hedgehog antagonists, methods and uses related thereto
|
|
GB0221539D0
(en)
|
2002-09-17 |
2002-10-23 |
Medical Res Council |
Methods of treatment
|
|
GB0230217D0
(en)
|
2002-12-27 |
2003-02-05 |
Biotica Tech Ltd |
Borrelidin-producing polyketide synthase and its uses
|
|
FR2850022B1
(fr)
|
2003-01-22 |
2006-09-08 |
Centre Nat Rech Scient |
Nouvelle utilisation de la mifepristone et de ses derives comme modulateurs de la voie de signalisation des proteines hedgehog et ses applications
|
|
ES2433493T3
(es)
|
2003-06-25 |
2013-12-11 |
Ottawa Hospital Research Institute |
Métodos y composiciones para modular el crecimiento de células pluripotenciales y la diferenciación
|
|
US20080118493A1
(en)
|
2003-07-15 |
2008-05-22 |
Beachy Philip A |
Elevated Hedgehog Pathway Activity In Digestive System Tumors, And Methods Of Treating Digestive Sytem Tumors Having Elevated Hedgehog Pathway Activity
|
|
WO2005033288A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog pathway antagonists
|
|
WO2005033286A2
(en)
|
2003-10-01 |
2005-04-14 |
Invitrogen Corporation |
Compositions and methods for synthesizing, purifying and detecting biomolecules
|
|
US20070231828A1
(en)
|
2003-10-01 |
2007-10-04 |
Johns Hopkins University |
Methods of predicting behavior of cancers
|
|
WO2005032343A2
(en)
|
2003-10-01 |
2005-04-14 |
The Johns Hopkins University |
Hedgehog signaling in prostate regeneration neoplasia and metastasis
|
|
WO2005042700A2
(en)
|
2003-10-20 |
2005-05-12 |
The Johns Hopkins University |
Use of hedgehog pathway inhibitors in small-cell lung cancer
|
|
US20070219250A1
(en)
|
2003-11-28 |
2007-09-20 |
Romi Singh |
Pharmaceutical Compositions of Nateglinide
|
|
AU2005325267B2
(en)
|
2004-04-30 |
2010-11-04 |
Curis Inc. |
Quinoxaline inhibitors of the hedgehog signalling pathway
|
|
EP2316832B1
(en)
|
2004-08-27 |
2017-03-08 |
Infinity Pharmaceuticals, Inc. |
Cyclopamine analogues and methods of use thereof
|
|
KR20170001725A
(ko)
|
2004-09-02 |
2017-01-04 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
|
US20070281040A1
(en)
|
2004-09-30 |
2007-12-06 |
The University Of Chicago |
Combination therapy of hedgehog inhibitors, radiation and chemotherapeutic agents
|
|
EP1804803A4
(en)
|
2004-10-28 |
2008-07-30 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS AS HEDGEHOG WALK MODULATORS
|
|
US20090208579A1
(en)
*
|
2004-12-27 |
2009-08-20 |
Eisai R & D Management Co., Ltd. |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
|
|
US20060252073A1
(en)
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
US8668905B2
(en)
|
2005-05-12 |
2014-03-11 |
University Of South Florida |
P53 vaccines for the treatment of cancers
|
|
EP1919480B1
(en)
|
2005-08-22 |
2013-01-16 |
The Johns Hopkins University |
Hedgehog pathway antagonists to treat disease
|
|
JP4712524B2
(ja)
|
2005-10-28 |
2011-06-29 |
富士通コンポーネント株式会社 |
入力デバイス及び電子機器
|
|
EP2314289A1
(en)
|
2005-10-31 |
2011-04-27 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
|
JP2009514889A
(ja)
|
2005-11-04 |
2009-04-09 |
メルク エンド カムパニー インコーポレーテッド |
癌を治療するためにｓａｈａ及びボルテゾミブを用いる方法
|
|
US20090156611A1
(en)
|
2005-11-11 |
2009-06-18 |
Licentia Ltd. |
Mammalian hedgehog signaling modulators
|
|
DK1957461T3
(en)
|
2005-11-14 |
2016-12-19 |
Genentech Inc |
Bisamidhæmmere the hedgehog-signalling
|
|
US20090263317A1
(en)
|
2005-12-15 |
2009-10-22 |
Wei Chen |
Method of screening the activity of the smoothened receptor to identify theraputic modulation agents or diagnose disease
|
|
EP1978973B1
(en)
|
2005-12-27 |
2011-11-16 |
Genentech, Inc. |
Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
|
|
EP1818411A1
(en)
|
2006-02-13 |
2007-08-15 |
Lonza AG |
Process for the preparation of optically active chiral amines
|
|
WO2008121102A2
(en)
|
2006-02-21 |
2008-10-09 |
The Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
|
US20110034498A1
(en)
|
2006-03-24 |
2011-02-10 |
Mcgovern Karen J |
Dosing regimens for the treatment of cancer
|
|
CN101420949A
(zh)
|
2006-04-14 |
2009-04-29 |
诺瓦提斯公司 |
联芳基甲酰胺类在治疗Hedgehog通路相关病症中的用途
|
|
UA93548C2
(uk)
|
2006-05-05 |
2011-02-25 |
Айерем Елелсі |
Сполуки та композиції як модулятори хеджхогівського сигнального шляху
|
|
DE102006031358A1
(de)
*
|
2006-07-05 |
2008-01-17 |
Schott Ag |
Verfahren zur Gehäusung optischer oder optoelektronischer Bauteile, sowie verfahrensgemäß herstellbares optisches oder optoelektronisches Gehäuseelement
|
|
US20100048944A1
(en)
|
2006-07-19 |
2010-02-25 |
Farhad Parhami |
Interactions of hedgehog and liver x receptor signaling pathways
|
|
PE20080948A1
(es)
|
2006-07-25 |
2008-09-10 |
Irm Llc |
Derivados de imidazol como moduladores de la senda de hedgehog
|
|
AU2007301993A1
(en)
|
2006-09-29 |
2008-04-03 |
Universiteit Gent |
Plant cell lines established from the medicinal plant Veratrum californicum
|
|
AU2007333528B2
(en)
|
2006-10-05 |
2013-10-17 |
The Johns Hopkins University |
Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
|
|
WO2008070357A2
(en)
|
2006-10-31 |
2008-06-12 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Smoothened polypeptides and methods of use
|
|
US20080103116A1
(en)
|
2006-11-01 |
2008-05-01 |
Jennings-Spring Barbara L |
Method of treatment and compositions of D-chiro inositol and phosphates thereof
|
|
US20080182859A1
(en)
|
2006-11-02 |
2008-07-31 |
Curis, Inc. |
Small organic molecule regulators of cell proliferation
|
|
WO2008063165A1
(en)
|
2006-11-20 |
2008-05-29 |
Satori Pharmaceuticals, Inc |
Compounds useful for treating neurodegenerative disorders
|
|
EP2084852A4
(en)
|
2006-11-20 |
2013-07-31 |
Thomson Licensing |
PROCESS FOR REMAINING REDUNDANT CONNECTIONS
|
|
TWI433674B
(zh)
|
2006-12-28 |
2014-04-11 |
Infinity Discovery Inc |
環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
|
|
WO2008089123A2
(en)
|
2007-01-12 |
2008-07-24 |
Infinity Discovery, Inc. |
Methods for analysis of hedgehog pathway inhibitors
|
|
FI123481B
(fi)
|
2007-02-05 |
2013-05-31 |
Upm Kymmene Corp |
Menetelmä painopaperin valmistamiseksi ja seoskoostumus
|
|
EP2129677B1
(en)
|
2007-03-07 |
2014-12-17 |
Infinity Discovery, Inc. |
Heterocyclic cyclopamine analogs and methods of use thereof
|
|
BRPI0808444A2
(pt)
|
2007-03-07 |
2017-06-06 |
Infinity Discovery Inc |
análogos de ciclopamina lactam e métodos de uso dos mesmos
|
|
JP5577104B2
(ja)
|
2007-03-14 |
2014-08-20 |
エクセリクシス パテント カンパニー エルエルシー |
ヘッジホッグ経路の阻害剤
|
|
JP5550352B2
(ja)
|
2007-03-15 |
2014-07-16 |
ノバルティス アーゲー |
有機化合物およびその使用
|
|
US9095589B2
(en)
|
2007-04-05 |
2015-08-04 |
Johns Hopkins University |
Chirally pure isomers of itraconazole for use as angiogenesis inhibitors
|
|
CN101663033B
(zh)
|
2007-04-18 |
2013-01-16 |
默沙东公司 |
作为smo拮抗剂的三唑衍生物
|
|
WO2008131354A2
(en)
|
2007-04-20 |
2008-10-30 |
The Curators Of The University Of Missouri |
Phytoestrogens as regulators of hedgehog signaling and methods of their use in cancer treatment
|
|
US9296776B2
(en)
|
2007-07-09 |
2016-03-29 |
Eastern Virginia Medical School |
Substituted nucleoside derivatives with antiviral and antimicrobial properties
|
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
|
WO2009049258A1
(en)
*
|
2007-10-12 |
2009-04-16 |
The Johns Hopkins University |
Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies
|
|
WO2009074300A2
(en)
|
2007-12-13 |
2009-06-18 |
Siena Biotech S.P.A. |
Hedgehog pathway antagonists and therapeutic applications thereof
|
|
CN101918420A
(zh)
|
2007-12-27 |
2010-12-15 |
无限药品股份有限公司 |
癌症治疗方法
|
|
US20100297118A1
(en)
|
2007-12-27 |
2010-11-25 |
Macdougall John |
Therapeutic Cancer Treatments
|
|
CN101917853B
(zh)
|
2007-12-27 |
2014-03-19 |
无限药品股份有限公司 |
立体选择性还原的方法
|
|
US20100222287A1
(en)
|
2007-12-27 |
2010-09-02 |
Mcgovern Karen J |
Therapeutic Cancer Treatments
|
|
WO2009099625A2
(en)
|
2008-02-08 |
2009-08-13 |
The Board Of Regents Of The University Of Texas System |
Cyclopamine tartrate salt and uses thereof
|
|
US20090246841A1
(en)
|
2008-03-26 |
2009-10-01 |
Jamieson Andrew C |
Methods and compositions for production of acetaldehyde
|
|
WO2009126840A1
(en)
|
2008-04-11 |
2009-10-15 |
Galaxy Biotech, Llc |
Combination of hgf inhibitor and hedgehog inhibitor to treat cancer
|
|
CL2009001479A1
(es)
|
2008-07-02 |
2010-01-04 |
Infinity Pharmaceuticals Inc |
Metodo para aislar un alcaloide del veratrum desglicosilado que comprende proporcionar un material de planta veratrum, poner en contacto con una solucion acuosa y extraer el material de la planta veratrum con un solvente para proporcionar un extracto que comprende dicho alcaloide.
|
|
CA2636807A1
(en)
|
2008-07-04 |
2010-01-04 |
Steven Splinter |
Methods for obtaining cyclopamine
|
|
US20100041663A1
(en)
|
2008-07-18 |
2010-02-18 |
Novartis Ag |
Organic Compounds as Smo Inhibitors
|
|
AR073591A1
(es)
|
2008-09-17 |
2010-11-17 |
Novartis Ag |
Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il)-piridin-3-il]-2-metil-4'-(trifluorometoxi)-[1,1'-bifenil]-3-carboxamida,composiciones farmaceuticas que las contienen,utiles para el tratamiento de carcinomas.
|
|
JP2012503025A
(ja)
|
2008-09-22 |
2012-02-02 |
エルロン・セラピューティクス・インコーポレイテッド |
精製されたポリペプチド組成物を調製するための方法
|
|
US20100081637A1
(en)
|
2008-10-01 |
2010-04-01 |
Innovia Skincare Corp. |
Eczema treatment with vitamin D and analogs thereof method, composition and cream
|
|
JP2012515792A
(ja)
|
2009-01-23 |
2012-07-12 |
キャンサー・リサーチ・テクノロジー・リミテッド |
ヘッジホッグ経路阻害剤
|
|
AR077490A1
(es)
|
2009-07-21 |
2011-08-31 |
Novartis Ag |
Composiciones farmaceuticas topicas para el tratamiento de una condicion hiperproliferativa de la piel
|
|
AU2010279325B2
(en)
|
2009-08-05 |
2016-10-20 |
Infinity Pharmaceuticals, Inc. |
Enzymatic transamination of cyclopamine analogs
|
|
MX2012005163A
(es)
*
|
2009-11-06 |
2012-11-22 |
Infinity Pharmaceuticals Inc |
Formulaciones orales de un inhibidor de la ruta de hedgehog.
|
|
EP2502078A1
(en)
|
2009-11-20 |
2012-09-26 |
Infinity Pharmaceuticals, Inc. |
Methods and compositions for treating hedgehog-associated cancers
|
|
US20110183948A1
(en)
|
2010-01-15 |
2011-07-28 |
Infinity Pharmaceuticals, Inc. |
Treatment of fibrotic conditions using hedgehog inhibitors
|
|
GB201010954D0
(en)
|
2010-06-29 |
2010-08-11 |
Edko Pazarlama Tanitim Ticaret |
Compositions
|
|
WO2012006584A2
(en)
|
2010-07-08 |
2012-01-12 |
Infinity Pharmaceuticals, Inc. |
Therapeutic regimens for hedgehog-associated cancers
|
|
US20120010230A1
(en)
|
2010-07-08 |
2012-01-12 |
Macdougall John R |
Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling
|
|
US9394313B2
(en)
|
2010-09-14 |
2016-07-19 |
Infinity Pharmaceuticals, Inc. |
Transfer hydrogenation of cyclopamine analogs
|
|
CN102085176A
(zh)
|
2010-12-31 |
2011-06-08 |
江苏中丹制药有限公司 |
一种纳米级伊曲康唑外用制剂、其制备方法及其用途
|
|
US8865765B2
(en)
|
2011-01-12 |
2014-10-21 |
The William M. Yarbrough Foundation |
Method for treating eczema
|
|
WO2013036830A1
(en)
|
2011-09-09 |
2013-03-14 |
The Board Of Trustees Of The Leland Standford Junior University |
Topical itraconazole formulations and uses thereof
|
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
|
KR20220044385A
(ko)
|
2012-12-14 |
2022-04-07 |
트레비 테라퓨틱스, 인코포레이티드 |
소양증을 치료하는 방법
|
|
US9452139B2
(en)
|
2013-03-14 |
2016-09-27 |
Novartis Ag |
Respirable agglomerates of porous carrier particles and micronized drug
|
|
JP6377245B2
(ja)
|
2014-03-24 |
2018-08-22 |
グアンドン ジョンシェン ファーマシューティカル カンパニー リミテッド |
Ｓｍｏ阻害剤としてのキノリン誘導体
|
|
US10369147B2
(en)
|
2015-06-04 |
2019-08-06 |
PellePharm, Inc. |
Topical formulations for delivery of hedgehog inhibitor compounds and use thereof
|
|
WO2017139497A1
(en)
|
2016-02-11 |
2017-08-17 |
PellePharm, Inc. |
Hedgehog inhibitor for use in relief of and treatment of pruritus or itching
|